PREVALENCE OF TURNER’S SYNDROME
DOI:
https://doi.org/10.61841/qggcj438Keywords:
Turners syndrome, prevalence, symptomsAbstract
Gonadal dysgenesis, 45 X condition, also known as Turner’s syndrome, is the condition in which a female is missing X monosomy partially or completely. There might be a difference in the signs and symptoms seen in the affected. There are many areas of concern which are to be checked regularly like cardiovascular malformations, hearing impairment and low thyroid function. There has been no discovery of a treatment to cure this gonadal dysgenesis. However, each of the symptoms can be reduced to help the patient live a more productive life and can reach his or her almost fullest potentials in the work they do or commitment they take up further in life.
Downloads
References
[1] Sybert VP, McCauley E. Turner's syndrome. New England Journal of Medicine. 2004 Sep 16;351(12):1227-38.
[2] Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics. 1998 Jan 1;101(1):e11-.
[3] Ellison JW, Wardak Z, Young MF, Robey PG, Laig-Webster M, Chiong W. PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Human molecular genetics. 1997 Aug 1;6(8):1341-7.
[4] Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Human molecular genetics. 2000 Mar 22;9(5):695-702.
[5] Lin AE, Lippe B, Rosenfeld RG. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics. 1998 Jul 1;102(1):e12-.
[6] Ho VB, Bakalov VK, Cooley M, Van PL, Hood MN, Burklow TR, Bondy CA. Major vascular anomalies in Turner syndrome prevalence and magnetic resonance angiographic features. Circulation. 2004 Sep 21;110(12):1694-700.
[7] Nielsen J, Wohlert M. Chromosome abnormalities found among 34910 newborn children: results from a 13- year incidence study in Århus, Denmark. Human genetics. 1991 Jan 1;87(1):81-3.
[8] Jacobs PA, Hassold TJ. The origin of numerical chromosome abnormalities. Advances in genetics. 1994 Dec;33:101-33.
[9] Lange J, Skaletsky H, van Daalen SK, Embry SL, Korver CM, Brown LG, Oates RD, Silber S, Repping S, Page DC. Isodicentric Y chromosomes and sex disorders as byproducts of homologous recombination that maintains palindromes. Cell. 2009 Sep 4;138(5):855-69.
[10] Author: Maala S Daniel, MBBS; Chief Editor: Luis O Rohena - Turner syndrome
[11] Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hultcrantz M, LandinWilhelmsen K, Lin A, Lippe B. Recommendations for the Diagnosis and Management of Turner Syndrome 1. The Journal of Clinical Endocrinology & Metabolism. 2001 Jul 1;86(7):3061-9.
[12] Chen J, Wildhardt G, Zhong Z, Roeth R, Weiss B, Steinberger D, Decker J, Blum WF, Rappold G. Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. Journal of medical genetics. 2009 Dec 1;46(12):834-9.
[13] Plotnick L, Attie KM, Blethen SL, Sy JP. Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience. Pediatrics. 1998 Aug 1;102(Supplement 3):479-81.
[14] Mccauley E, Feuillan P, Kushner H, Ross JL. Psychosocial development in adolescents with Turner syndrome. Journal of Developmental & Behavioral Pediatrics. 2001 Dec 1;22(6):360-5.
[15] Elder DA, Roper MG, Henderson RC, Davenport ML. Kyphosis in a turner syndrome population. Pediatrics. 2002 Jun 1;109(6):e93-.
[16] Hultcrantz M. Ear and hearing problems in Turner's syndrome. Acta oto-laryngologica. 2003 Feb 1;123(2):253-7.
[17] Hjerrild BE, Mortensen KH, Gravholt CH. Turner syndrome and clinical treatment. British Medical Bulletin. 2008 Jun 1;86(1):77-93.
[18] Foudila T, Söderström-Anttila V, Hovatta O. Turner's syndrome and pregnancies after oocyte donation. Human reproduction. 1999 Feb 1;14(2):532-5.
[19] Bodri D, Vernaeve V, Figueras F, Vidal R, Guillen JJ, Coll O. Oocyte donation in patients with Turner’s syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy. Human reproduction. 2006 Mar 1;21(3):829-32.
[20] Karnis MF, Zimon AE, Lalwani SI, Timmreck LS, Klipstein S, Reindollar RH. Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertility and sterility. 2003 Sep 30;80(3):498-501.
[21] Price WH, Clayton JF, Collyer S, De Mey R, Wilson J. Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. Journal of Epidemiology and Community Health. 1986 Jun 1;40(2):97-102.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
